Biosimilars Versus Biologics – How About Both?

Pharmacy benefit managers (PBMs) are using the availability of alternatives, both biosimilars and their reference biologics, as part of an overall strategy to remove costs from the health care system. This direct competition, in turn, lowers patients’ costs.